Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1200 of 1467 entries
View as:

Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01013324 Org: User:
Start: 01/31/10 End: 03/31/13 Due: 03/31/14

Evaluation of Efficacy of Dellegra in Exposure Unit

Phase: N/A Priority: Normal
NCT ID: NCT02175485 Org: User:
Start: 06/30/14 End: 06/30/14 Due: 06/30/15

First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL

Phase: N/A Priority: Normal
NCT ID: NCT04401020 Org: User:
Start: 07/24/20 End: 03/17/26 Due: 03/17/27

A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT06073119 Org: User:
Start: 10/26/23 End: 12/11/24 Due: 12/11/25

Proof of Biological Activity of SAR100842 in Systemic Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01651143 Org: User:
Start: 01/31/13 End: 04/30/14 Due: 04/30/15

First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Phase: N/A Priority: Normal
NCT ID: NCT05086315 Org: User:
Start: 12/08/21 End: 05/01/29 Due: 05/01/30

Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)

Phase: N/A Priority: Normal
NCT ID: NCT03992417 Org: User:
Start: 06/11/19 End: 03/31/27 Due: 03/31/28

Docetaxel in Locally Advanced Gastric Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00343239 Org: User:
Start: 06/30/06 End: 03/31/12 Due: 03/31/13

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00688701 Org: User:
Start: 05/31/08 End: 12/31/09 Due: 12/31/10

PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00296803 Org: User:
Start: 11/30/05 End: 08/31/06 Due: 08/31/07

An Open-label, Non-comparative Study to Document the Tolerability to Ramipril in Patients With at Least One High Risk for Developing a Major Cardiovascular Event

Phase: N/A Priority: Normal
NCT ID: NCT03099213 Org: User:
Start: 11/01/08 End: 04/23/10 Due: 04/23/11

Ketek in CAP / AECB in Ambulatory Adult Patients

Phase: N/A Priority: Normal
NCT ID: NCT00546676 Org: User:
Start: 05/31/04 End: 12/31/04 Due: 12/31/05

Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants.

Phase: N/A Priority: Normal
NCT ID: NCT01214889 Org: User:
Start: 09/30/10 End: 12/31/11 Due: 12/31/12

Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00681798 Org: User:
Start: 07/31/06 End: 06/30/09 Due: 06/30/10

A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02688933 Org: User:
Start: 05/05/16 End: 06/19/17 Due: 06/19/18

Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00388583 Org: User:
Start: 09/30/06 End: 09/30/08 Due: 09/30/09

A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Phase: N/A Priority: Normal
NCT ID: NCT04074187 Org: User:
Start: 10/21/19 End: 05/19/21 Due: 05/19/22

Efficacy and Safety of Volinanserin on Sleep Maintenance Insomnia - Polysomnographic Study

Phase: N/A Priority: Normal
NCT ID: NCT00464243 Org: User:
Start: 04/30/07 End: 01/31/08 Due: 01/31/09

Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) Patients

Phase: N/A Priority: Normal
NCT ID: NCT02411825 Org: User:
Start: 03/31/15 End: 01/31/16 Due: 01/31/17

Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With Oral Antidiabetic Drugs (OADs) in Patients With Diabetes Mellitus, Type 2 (DMT2)

Phase: N/A Priority: Normal
NCT ID: NCT00659477 Org: User:
Start: 03/31/08 End: 06/30/09 Due: 06/30/10

Dermacyd Teen Care Tangerina Mix - Compatibility

Phase: N/A Priority: Normal
NCT ID: NCT00761800 Org: User:
Start: 05/31/08 End: 05/31/08 Due: 05/31/09

First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT04000282 Org: User:
Start: 08/19/19 End: 09/04/23 Due: 09/04/24

Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00705822 Org: User:
Start: 08/31/06 End: 07/31/09 Due: 07/31/10

Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00327171 Org: User:
Start: 05/31/06 End: 03/31/10 Due: 03/31/11

EFESO - EFficacy Enterogermina Small Intestinal Bacterial Overgrowth

Phase: N/A Priority: Normal
NCT ID: NCT00331994 Org: User:
Start: 04/30/06 End: 07/31/08 Due: 07/31/09